SB431542

For research use only. Not for use in humans.

目录号:S1067

SB431542 Chemical Structure

CAS No. 301836-41-9

SB431542是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为94 nM,对ALK5的作用比对p38、MAPK和其他激酶强100倍。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 1171.35 现货
RMB 896.27 现货
RMB 3834.82 现货
RMB 10401.3 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的SB431542发表文献423篇:

产品安全说明书

TGF-beta/Smad抑制剂选择性比较

生物活性

产品描述 SB431542是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为94 nM,对ALK5的作用比对p38、MAPK和其他激酶强100倍。
特性 SB-431542在EGFR激酶域引起点突变,或上调HER3下游信号通路。
靶点
ALK4 [2]
(Cell-free assay)
ALK7 [2]
(Cell-free assay)
ALK5 [1]
(Cell-free assay)
94 nM
体外研究

SB-431542作用于A498细胞无细胞毒性,LD50大于30 μM。[1] SB-431542也抑制ALK4和ALK7,这两种含有磷酸化Smad2。SB-431542对ALK1, ALK2, ALK3,和ALK6抑制作用不大, 这四种含磷酸化Smad1。SB-431542选择性抑制内生的活化素,而对BMP信号没有作用效果。SB-431542可以诱导Smad2/Smad4和Smad3/Smad4依赖的转录。[2] 在A498细胞中, SB-431542抑制TGF-β1诱导的胶原Iα1 和PAI-1 mRNA,IC50分别为60和50 nM。此外,SB-431542抑制TGF-β1诱导的纤连蛋白mRNA和蛋白,IC50分别为62和22 nM。 [3]SB-431542抑制TGF-β调节的生长因子,包括PDGF-A, FGF-2 和HB-EGF, 可以增强MG63细胞增殖。SB-431542也抑制TGF-β诱导的 c-Myc和p21WAF1/CIP1。[4] 在FET, RIE, 和Mv1Lu细胞中,SB-431542 明显抑制TGF-β诱导的G1 期阻滞,且SB-431542诱导细胞周期S期细胞数累积。在NMuMG和PANC-1细胞中,SB-431542也抑制TGF-β调节的上皮细胞向间质转型(EMT)。[5] SB-431542通过人类DC的功能成熟和IL-12产生而诱导NK活性。[6]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HEK293T NEL5PFVHfW6ldHnvckBCe3OjeR?= MmXXNVAh|ryP Mn;lNlIhcA>? M3f6WmROW09? NHS2WZdKdmirYnn0d{BVT0KUMjDzbYdv[WyrbnegbY4hcHWvYX6gTGVMOjl|VDDj[YxteyCjc4Pld5Nm\CCjczDJcohq[mm2aX;uJI9nKFOPQVSgZYN1cX[jdHnvckB4cXSqIFnDOVAhd2ZiMD6wOlbPxE1? M2DvfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUOwOlI3Lz5{M{GzNFYzPjxxYU6=
H1299 M124VG1q\3KjdHnvckBCe3OjeR?= NUfXcY97OSEQvF2= MkKyNVIuOjRiaB?= NGXH[G1FVVOR MWPJcoR2[2W|IHHueIlucWe{YYTvdpkh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDINVI6QSClZXzsd{Bie3Onc4Pl[EBieyCLbnjpZol1cW:wIH;mJINmdGxibXnndoF1cW:wIIfpeIghUUN3MDDv[kAxNjYQvF2= M3G4TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEG3OFc6Lz5{NESxO|Q4QTxxYU6=
HaCaT MnjVSpVv[3Srb36gRZN{[Xl? MXezMlIuPTBizszN NU[zdnJpOTVibXnu NEn4[3RFVVOR NVnGd4k2UW6qaXLpeJMhXEeIYnX0ZUBz\WOncITvdkBqdiCqdX3hckBJ[UOjVDDj[YxteyCjc4Pld5Nm\CCjczDTcYFlKHCqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6xO|LPxE1? MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODlzOU[3PEc,OjB7MUm2O|g9N2F-
HepG2 M3LoXWZ2dmO2aX;uJGF{e2G7 Mlm5NVIhcA>? MX\EUXNQ NHLuRXBKdmirYnn0d{BVT0[ULUGgbY4hcHWvYX6gTIVxTzJiY3XscJMh\XiycnXzd4lv\yCSQVmtcJVkcW[ncnHz[UB4cXSqIFnDOVAhd2ZiMD6yOe69VQ>? MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTlzNEC2PEc,OTl7MUSwOlg9N2F-
CHO-HIR M4f3V2Z2dmO2aX;uJGF{e2G7 M4C3N|AvODFvMzFOwG0> MlrmNkBp MXHEUXNQ MkL6TY5pcWKrdIOgWGdH[mW2YT3pcoR2[2WmIHTve45{fHKnYX2geJJidnOlcnnweIlwdmGuIHHjeIl3[XSrb36gc4YhSUyNNTDlfJBz\XO|ZXSgbY4hS0iRLVjJVkBk\WyuczDhd5Nme3OnZDDhd{BqdnS{YXPlcIx2dGG{IITyZY5{dG:lYYTpc44hd2ZiRVfGVE1UdWGmMjD3bZRpKEmFNUCgc4YhOC5|Nd88US=> NYD5[2ZYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSwOVUxPDZpPkK0NFU2ODR4PD;hQi=>
Sf9 MojoSpVv[3Srb36gRZN{[Xl? NVXDSZhPOiCq M1XyV2ROW09? MkL3TY5pcWKrdIOgbJVu[W5icnXjc41jcW6jboSgRWxMPSCyaH;zdIhwenmuYYTpc44h\XiycnXzd4VlKGmwIGPmPUBk\WyuczD3bZRpKEmFNUCgc4YhOS53NENOwG0> NVTmdnFqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe1OVI2ODdpPkG3OVUzPTB5PD;hQi=>
C32 NHXyOopHfW6ldHnvckBCe3OjeR?= NYXpXmxyOTBizszN MkfaNlBp M4HvPGlvcGmkaYTzJHRzgXCjbn;zc41iKGO{dYrpJHkhcW6oZXP0bY9vNWmwZIXj[YQhXEeIYnX0ZUB{cWewYXzpcochcW5ibXnub{BEOzJiY3XscJMh[XRiMUCgeW0> M3;oe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NUK2O|U4Lz5zN{WyOlc2PzxxYU6=
Mouse embryo cardiomyocytes MXjGeY5kfGmxbjDBd5NigQ>? MYmxNEDPxE1? NHX2SlUyKGh? MkjTTY5pcWKrdIOgbY53[XOrb36gc4YhXHK7cHHuc5NwdWFiY4L1fokhYSCrbjDtc5V{\SCnbXLyfY8h[2G{ZHnvcZlw[3m2ZYOgZZN{\XO|ZXSgZZMheGG2aH;n[Y4hcW6oZXP0bY9vKGG2IEGwJJVO NIP3XWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{WyOlc2Pyd-MUe1NlY4PTd:L3G+
Mouse embryo cardiomyocytes M1f5bGZ2dmO2aX;uJGF{e2G7 NUG1e|drOTBizszN MX2xJIg> NVrR[mkzUW6qaXLpeJMhXEeILXLleIEuOS2rbnT1Z4VlKFOvYXSyJJBpd3OyaH;yfYxifGmxbjDpckBud3W|ZTDlcYJzgW9iY3Hy[IlwdXmxY4n0[ZMh[XRiMUCgeW0> NVnE[GdFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe1NlY4PTdpPkG3OVI3PzV5PD;hQi=>
Mouse embryo cardiomyocytes M1LGTmZ2dmO2aX;uJGF{e2G7 NWDa[oF5OTBizszN NU\CWpd7OSCq M3rZNmlvcGmkaYTzJHRzgXCjbn;zc41iKGO{dYrpJGRuOjiFIHnu[oVkfGmxbj3pcoR2[2WmIGPtZYQzKHCqb4PwbI9zgWyjdHnvckBqdiCvb4Xz[UBmdWK{eX:gZ4Fz\GmxbYnvZ5l1\XNiYYSgNVAhfU1? NHyzSok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{WyOlc2Pyd-MUe1NlY4PTd:L3G+
Trypanosoma cruzi trypomastigotes MoPKRY51cW2rY4LvZolidCCDc4PhfS=> NGPVRlkyOCEQvF2= M{DoWFQhcA>? NHP4UZpKdmS3Y3XzJIFvfGm2conwZY5we2:vYXygZYN1cX[rdImgZYdicW6|dDDUdplx[W6xc3;tZUBkenW8aTD0dplxd22jc4Tp[491\XNiYYPz[ZN{\WRiYYOg[YZn\WO2IH;uJJBiemG|aYTlJI1wenCqb3zv[5kh[XRiMUCgeW0> NGrT[2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{WyOlc2Pyd-MUe1NlY4PTd:L3G+
Mouse cardiomyocytes MX3BcpRqdWmlcn;ibYFtKEG|c3H5 M3nwclExKM7:TR?= MYq0JIg> MkLNTY5lfWOnczDhcpRqfHK7cHHuc5NwdWGuIHHjeIl3cXS7IHHnZYlve3RiVIL5dIFvd3OxbXGgZ5J2gmliWTDpckBud3W|ZTDjZZJlcW:veX;jfZRmeyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4YhcW62cnHj[YxtfWyjcjDhcYF{fGmpb4Tld{BifCBzMDD1US=> MlLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd3Mk[3OVcoRjF5NUK2O|U4RC:jPh?=
Mouse cardiomyocytes NXTjeWt6SW62aX3pZ5Jw[mmjbDDBd5NigQ>? NGTUU2UyOCEQvF2= MmPoPVYhcA>? NYTiN5FVUW6mdXPld{BidnSrdIL5dIFvd3OxbXHsJIFkfGm4aYT5JIFo[Wmwc4SgWJJ6eGGwb4PvcYEh[3K3enmgXUBqdiCvb4Xz[UBk[XKmaX;tfY9kgXSnczDhd5Nme3OnZDDhd{BKdmirYnn0bY9vKG:oIITyfZBwdWG|dHnnc5RmKHKnbHXhd4Uh[XRiMUCgeW0> NVmzUlRHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe1NlY4PTdpPkG3OVI3PzV5PD;hQi=>
HaCaT NHjTSoxHfW6ldHnvckBCe3OjeR?= MWqwMlA2KM7:TR?= MXuyJIg> NX3iRnpbTE2VTx?= M3Hlb2Rw\XNibn;0JIlvcGmkaYSgWGdHNWKndHGgbY5lfWOnZDDBUGs2KGGldHn2bZR6KGmwIFjhR4FVKGOnbHzzJIF{e2W|c3XkJIF{KHB|VGCtcJVkcW[ncnHz[UBz\XCxcoTldkBi[3Srdnn0fUBifCByLkC1JJVO Ml;EQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd3NUK1NFcoRjF5NUWyOVA4RC:jPh?=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
phospho-SMAD3 / Phospho-p38 ; 

PubMed: 17113264     


Quiescent IMR-90 cells were treated with/without TGF-β1 (2 ng/ml) in the presence or absence of increasing concentrations of the TGF-βR1(ALK5) inhibitor, SB431542. Cell lysates were collected after 45 min and assessed by SDS-PAGE followed by western immunoblotting for phospho-SMAD3 and phospho-p38 MAPK. The blots were then striped and probed for total SMAD3 and p38 MAPK, respectively.

Y397 phospho-FAK; 

PubMed: 17113264     


Quiescent IMR-90 cells were treated with TGF-β1 (2 ng/ml) in the presence/absence of the p38 MAPK inhibitor, SB203580 (6 μM). Cell lysates collected after 16 h were assessed for Y397-phosphorylated FAK by SDS-PAGE and western immunoblotting. Blots were stripped and probed for total FAK.

pSmad2 / p-AKT / E-cadherin / vimentin / snail / slug; 

PubMed: 26269769     


B16-pldMock cells and B16-pldNodal cells were treating with SB431542 (10 mM) in a time dependent manner, and then the protein was collected for Western blotting analysis.

CK18 / Fibronectin / Vimentin; 

PubMed: 30134011     


Representative Western blots (upper panel) and densitometric analysis (lower panel) for E‐cadherin, CK18 (epithelial markers), fibronectin and vimentin (mesenchymal markers) normalized to β-actin in HepG2 and BEL7402 cells with or without SB431542 treatment in CM and HBSS.

17113264 26269769 30134011
Growth inhibition assay
Cell viability; 

PubMed: 28125630     


Cells were treated with 1 mg/L, 4 mg/L, and 16 mg/L of fluoride with or without 10μmol/L SB431542 for 4 and 7 days. MTT assay was used to detect cell viability. Absorbance was measured at 490 nm in aspectrophotometer. Average optical density (OD) value of cells viability was represented as mean±SD (n = 8) (*P < 0.05, **P < 0.01 compare with control group; aa P< 0.05, compare with SB431542 group).

28125630
Immunofluorescence
Smad2/3; 

PubMed: 19619490     


MEFs were treated with 25 mM glucose, TGF-β or glucose and SB431542 for 30 min, and the subcellular localization of Smad2/3 was visualized. DAPI was used to stain the nuclei.

19619490
Immunofluorescence
Na+/K+-ATPase; 

PubMed: 23451286     


Blocking the TGF-receptor signaling by SB431542 enabled the subcellular localization of Na+/K+-ATPase and ZO-1 at the plasma membrane. Scale bar: 100 μm.

23451286
ELISA
collagen 1; 

PubMed: 23451286     


ELISA assay revealed that SB431542 significantly downregulated the secretion of type I collagen to the culture supernatant. **P<0.05.

23451286
体内研究 在结肠癌模型中,SB-431542导致 毒性T淋巴细胞激活 (CTL) ,且通过TGF-ß 抑制的DC功能改变,产生抗癌免疫效果。[6]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:[1]
- 合并

激酶实验:

SB-431542溶解在DMSO中,浓度为10 mM。在杆状病毒表达系统中,TGFβRI的激酶域,:第200号氨基酸到C-端,和全长Smad3蛋白表达作为 N-端谷胱甘肽S转移酶(GST)融合蛋白。加入谷胱甘肽凝胶来纯化蛋白。用0.1 M 无菌过滤的碳酸氢钠(pH 为7.6)包被FlashPlates,每100 μL中加入700 ng GST-Smad3。实验buffer包含50 mM HEPES (pH 为7.4), 5 mM MgCl2, 1 mM CaCl2, 1 mM DTT, 100 mM GTP, 3 μM ATP,0.5 μCi/孔33P-ATP, 及85 ng GST-ALK5。 在30oC下温育3小时。在Packard TopCount 96孔闪烁计数器上读数。
细胞实验:[1]
- 合并
  • Cell lines: A498细胞
  • Concentrations: 100 μM 左右
  • Incubation Time: 48小时
  • Method: A498细胞按每孔5-10×103个接种在96孔板上。细胞血清饥饿处理24小时,然后用SB431542处理48小时,测定细胞毒性。然后加入XTT标签和细胞温育4小时,测定细胞活力。
    (Only for Reference)
动物实验:[6]
- 合并
  • Animal Models: 腹腔注射结肠-26肿瘤细胞的BALB/c鼠
  • Dosages: 1 μM 溶液, 100 μL/鼠
  • Administration: 腹腔注射
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 76 mg/mL (197.71 mM)
Ethanol 3 mg/mL (7.8 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
2% DMSO+30% PEG 300+ddH2O
5mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 384.39
化学式

C22H16N4O3

CAS号 301836-41-9
储存条件 粉状
溶于溶剂
别名 N/A

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    I would appreciate it if you can help me in figuring out the formulation for this drug in vivo experiments.

  • 回答:

    S1067 SB431542 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30 mg/ml is a suspension for oral gavage. It can also be dissolved in 2% DMSO+30% PEG 300+ddH2O at 5 mg/ml as a clear solution for IP injection.

TGF-beta/Smad Signaling Pathway Map

TGF-beta/Smad Inhibitors with Unique Features

相关TGF-beta/Smad产品

Tags: 购买SB431542 | SB431542供应商 | 采购SB431542 | SB431542价格 | SB431542生产 | 订购SB431542 | SB431542代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID